University of Maryland School of Medicine researchers have sequenced the genome of the common cold, the first step to developing effective treatments.
“Having the genetic blueprint of a pathogen provides a brand-new starting point for understanding how they work and thinking about how to more rationally develop therapies and vaccines,” said co-investigator Dr. Claire Fraser-Liggett, director of the Institute for Genomic Sciences and professor of medicine and microbiology at the medical school.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.